# Isotoxic Intensity Modulated Radiotherapy (IMRT) in Stage III Non Small Cell Lung Cancer (NSCLC) - A Feasibility Study

> **NCT01836692** · NA · COMPLETED · sponsor: **Prof Corinne Faivre-Finn** · enrollment: 38 (actual)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **RADIATION:** Intensity Modulated Radiotherapy treatment

## Key facts

- **NCT ID:** NCT01836692
- **Lead sponsor:** Prof Corinne Faivre-Finn
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2016-10
- **Final completion:** 2018-06
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2018-10-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01836692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01836692, "Isotoxic Intensity Modulated Radiotherapy (IMRT) in Stage III Non Small Cell Lung Cancer (NSCLC) - A Feasibility Study". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01836692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*